The Lymphoma Research Foundation offers a wide range of lymphoma-focused educational activities designed to increase the knowledge, skills and performance of healthcare professionals and to maximize the quality of care for lymphoma patients.
- Meetings for Physicians and Other Healthcare Professionals: Lymphoma Rounds
- Frontline – A Lymphoma Rounds Publication
Resources for Your Patients
LRF also provides the latest information to people with lymphoma and their loved ones through a comprehensive series of educational programs, publications and support services. These programs and services are helpful resources for your patients, and valuable supplements to your current practices.
- Educational Workshops
- Support Services
- Booklets and Fact Sheets
Resources for Researchers
LRF remains dedicated to finding a cure for lymphoma through an aggressively-funded program for researchers. Ongoing research opportunities include:
Real-World Perspectives in Managing CLL Treatment
Support for this activity has been provided through educational grants from AbbVie Inc. and AstraZeneca Pharmaceuticals.
Management options for chronic lymphocytic leukemia (CLL) have expanded in recent years. The emergence of new immunotherapeutic and targeted agents for both the first-line and relapsed/refractory settings—though of course beneficial for CLL patients—represents a challenge to clinicians, who must navigate the indicated uses, mechanisms of action, and toxicity profiles of these new agents. In determining optimal treatment plans, clinicians are also confronted with significant advances in the use of cytogenetic and molecular tests to stratify risk and determine prognosis.
This interactive activity presents the points of view of doctors and patients on issues relating to current challenges in CLL care. Each point of view is followed by a brief discussion that will help oncologists and hematologist-oncologists select the most appropriate targeted therapies, taking into account patient genetics, treatment adverse events, and previous treatments.